Vital Therapies,
美國生命治療公司是致力于研發肝臟疾病醫療新技術的高科技公司,目前已成功研制全球首例基于人源肝細胞的生物人工肝(ELAD?),產品在美國和中國均處于臨床試驗階段。
Vital Therapies, Inc. is a biotherapeutic company developing a cell-based therapy targeting the treatment of acute liver failure. The company's lead product-candidate, ELAD, is an extracorporeal bio-artificial liver currently in phase 3 clinical trials. Vital Therapies, Inc. is based in San Diego, California.